Financials
Financial year 2025
FEVERY PHARMA from Brugge, company number BE0552675811, closed financial year 2025 with a result of € 160,584 after tax. For that financial year FEVERY PHARMA recorded a gross margin of € 166,477 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 96,258 to € 160,584. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 1.2 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 160,584
▲ 67% vs 2024
Profit after tax over the fiscal year.
€ 225,795
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 126,666 paid out
79 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 50,000
▼ 33% vs 2024
Loans from banks and other lenders, long and short.
€ 3,826
▲ 209% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,984
▲ € 25,307 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,105 | € 163,600 | € 157,802 | € 166,477 | ▲ 5% |
| Profit after taxes | € 347,163 | € 96,651 | € 96,258 | € 160,584 | ▲ 67% |
| Equity | € 988,439 | € 1,070,090 | € 1,145,097 | € 1,179,015 | ▲ 3% |
| Total debts | € 696,079 | € 596,706 | € 359,642 | € 324,187 | ▼ 10% |
| Cash | € 160,040 | € 383,066 | € 178,396 | € 225,795 | ▲ 27% |
| Retained profit | € 761,132 | € 842,783 | € 917,791 | € 951,709 | ▲ 4% |
| Dividend | € 10,750 | € 15,000 | € 21,250 | € 126,666 | ▲ € 105,416 |
| Bank debt | € 158,691 | € 103,267 | € 75,000 | € 50,000 | ▼ 33% |
| Balance sheet total | € 1,684,517 | € 1,666,796 | € 1,504,740 | € 1,503,202 |
Key figures of FEVERY PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FEVERY PHARMA?
What happened at FEVERY PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 160,584 (▲ 67% vs 2024). Source: NBB ↗
- Sofie Monbaliu became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 347,163 profit in 2022 to € 160,584 profit in 2025.
Paid € 169,347 in corporate taxes since 2022.
Best year ever: 2022, with € 347,163 profit.
Paid out € 173,666 in dividends to the owners in total.
A new publication or filing at FEVERY PHARMA? We notify you, reason included.
Follow FEVERY PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind FEVERY PHARMA are Wouter Fevery and Sofie Monbaliu. It owns 99.6% of Fevery-Dewitte itself.
Directors
According to the 2025 annual accounts
Sofie Monbaliu
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Zuidzandstraat 1
8000 Brugge
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0552.675.811
- VAT number
- BE 0552.675.811
- Registered office
- Zuidzandstraat 1, 8000 Brugge
- Names & denominations
- FEVERY PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 May 2014
- Peppol
- Active · Active since 5 Sept 2025
- Contact
- apotheekfevery.be
- Activities · NACE
Activiteiten van holdings
Holdings
Vermogensbeheer